Frequency of multidrug resistant pathogens in healthcare associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Common organisms causing community acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Low frequency of resistant pathogens in nursing home acquired pneumonia: A prospective study and systematic review Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Clinical impact of a prediction score for drug-resistance in community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Resistant pathogens that cause pneumonia: a global perspective Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia Year: 2014
Relationship between bacterial sensivity pattern and hospital antibiotic consumption,in patients with community acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Factors affecting treatment success in community acquired pneumonia (CAP) Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Community acquired legionella pneumophila pneumonia, clinical characteristics, outcomes and prognostic factors Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016
Microcalorimetry for bacterial strain discrimination - a first step in developing a novel technique for the diagnosis of severe infections Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
Can the broad-spectrum antibiotics improve the prognoses of high-risk nursing- and healthcare-associated pneumonia? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
High prevalence of resistant bacterial infections in patients with tracheostomy due to neuromuscular disease (NMD) Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Biomarkers to discriminate bacterial, viral and mixed community acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013